Article
CCT-217: A Landmark Gene Silencing Therapeutic for Weight Loss That Enhances Lean Mass Composition, Reduces Visceral, Subcutaneous Fat and Restores Metabolic Health in Obesity through Browning
2024-12-30
Abstract excerpt
According to the CDC, between 2017 and March 2020, 41.9% of U.S. adults aged 20 and older had obesity, with 9.2% experiencing severe obesity, affecting over 100 million and 22 million adults, respectively. Obesity prevalence increased from 30.5% in 1999-2000 to 41.9% in 2017-2020, while severe obesity rose from 4.7% to 9.2%. As per CDC projection, by 2030, nearly half of the US adults will be obese, with a quarter...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2cbdc994-e3dc-56a9-87a5-21f2e5f53486
- DOI
- 10.1101/2024.12.30.630715
